iBio Inc.

NASDAQ: IBIO · Real-Time Price · USD
0.74
0.06 (9.14%)
At close: Aug 15, 2025, 3:59 PM
0.75
1.47%
After-hours: Aug 15, 2025, 07:56 PM EDT

iBio Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Cash & Equivalents
14.21M 4.3M 22.68M 77.4M
Short-Term Investments
n/a n/a 10.85M 19.57M
Long-Term Investments
n/a 1.96M 7.63M 6.66M
Other Long-Term Assets
1.32M 2.01M 7.73M 6.68M
Receivables
713K 204K 6.1M 5.53M
Inventory
n/a 21.09M 3.9M 27K
Other Current Assets
749K 21.75M n/a n/a
Total Current Assets
15.67M 26.26M 45.07M 104.6M
Property-Plant & Equipment
6.37M 7.55M 41.76M 34.74M
Goodwill & Intangibles
5.37M 5.39M 4.85M 952K
Total Long-Term Assets
13.06M 14.95M 54.34M 42.37M
Total Assets
28.73M 41.21M 99.41M 146.97M
Account Payables
358K 1.85M 4.26M 2.25M
Deferred Revenue
200K 4.19M 100K 423K
Short-Term Debt
218K 12.94M 22.16M 967K
Other Current Liabilities
761K 2.35M 754K 1.93M
Total Current Liabilities
3.84M 21.58M 30.44M 6.64M
Long-Term Debt
766K n/a n/a n/a
Other Long-Term Liabilities
63K 768K 1.97M n/a
Total Long-Term Liabilities
3.57M 4.24M 5.49M 31.75M
Total Liabilities
7.41M 25.83M 35.92M 38.4M
Total Debt
4.46M 17.07M 27.79M 32.72M
Common Stock
9K 20K 9K 217K
Retained Earnings
-313.85M -288.94M -223.93M -173.63M
Comprehensive Income
n/a n/a -213K -63K
Shareholders Equity
21.32M 15.38M 63.48M 108.58M
Total Investments
1.3M 1.96M 10.85M 19.57M